Showing results (2341-2350 of 2,892) with videos related to
Sort By:
Pageof 290
Cell Cycle (Georgetown, Tex.)|September 25, 2007
Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicinMaria A Tapia, Irene González-Navarrete, Alba Dalmases, et al.BJOG : an International Journal of Obstetrics and Gynaecology|July 15, 2018
Urinary stress incontinence and other maternal outcomes 2 years after caesarean or vaginal birth for twin pregnancy: a multicentre randomised trialE K Hutton, M E Hannah, A R Willan, et al.Cancer Medicine|December 14, 2020
Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast CancerAbirami Sivapiragasam, Prashanth Ashok Kumar, Ethan S Sokol, et al.JMIR Mhealth and Uhealth|May 14, 2021
The Use of SMS Text Messaging to Improve the Hospital-to-Community Transition in Patients With Acute Coronary Syndrome (Txt2Prevent): Results From a Pilot Randomized Controlled TrialEmily S Ross, Brodie M Sakakibara, Martha H Mackay, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2022
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate CancerUmang Swami, Ryon P Graf, Roberto H Nussenzveig, et al.BMJ (Clinical Research Ed.)|October 3, 2022
Emulating the GRADE trial using real world data: retrospective comparative effectiveness studyYihong Deng, Eric C Polley, Joshua D Wallach, et al.BJOG : an International Journal of Obstetrics and Gynaecology|September 3, 2015
Maternal outcomes at 3 months after planned caesarean section versus planned vaginal birth for twin pregnancies in the Twin Birth Study: a randomised controlled trialE K Hutton, M E Hannah, S Ross, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2019
Calculating the Tumor Nuclei Content for Comprehensive Cancer Panel TestingMasashi Mikubo, Katsutoshi Seto, Atsuko Kitamura, et al.Cancer Cell|August 4, 2009
Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorderKatherine I Oravecz-Wilson, Steven T Philips, Omer H Yilmaz, et al.JCO Precision Oncology|September 24, 2025
Clinical and Pathologic Landscapes of Delta-Like Ligand 3 and Seizure-Related Homolog Protein 6 Expression in Neuroendocrine CarcinomasJessica S Ross, Rohit Thummalapalli, Kristine Lacuna, et al.Pageof 290